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The UK's Improving Access to Psychological Therapies (IAPT) initiative provides evidence-based psy-
chological interventions for mild to moderate common mental health problems in a primary care setting.
Predictors of treatment response are unclear. This study examined the impact of personality disorder
status on outcome in a large IAPT service. We hypothesised that the presence of probable personality
disorder would adversely affect treatment response.
Method: We used a prospective cohort design to study a consecutive sample of individuals (n ¼ 1249).
Results: Higher scores on a screening measure for personality disorder were associated with poorer
outcome on measures of depression, anxiety and social functioning, and reduced recovery rates at the
end of treatment. These associations were not confounded by demographic status, initial symptom
severity nor number of treatment sessions. The presence of personality difﬁculties independently pre-
dicted reduced absolute change on all outcome measures.
Conclusions: The presence of co-morbid personality difﬁculties adversely affects treatment outcome
among individuals attending for treatment in an IAPT service. There is a need to routinely assess for the
presence of personality difﬁculties on all individuals referred to IAPT services. This information will
provide important prognostic data and could lead to the provision of more effective, personalised
treatment in IAPT.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In 2008, the Improving Access to Psychological Therapies
(IAPT) programme was established in England, in order to
improve access to psychological interventions for people with
depression and anxiety. IAPT services offer a single point of access
for evidence-based psychological therapies that are recom-
mended by the National Institute of Health and Clinical Excellence
(NICE) for mild to moderate anxiety or depression (e.g. cognitive
behaviour therapy; CBT) (Clark, 2011; Layard et al., 2006). IAPT
services now receive almost 900,000 referrals per annum with
more than half of referred individuals entering treatment. Goddard), janet.wingrove@
oran).
Ltd. This is an open access article u(Community and Mental Health team Health and Social Care
Information Centre, 2014, 2015; Gyani, Shafran, Layard, & Clark,
2011). The services use a ‘stepped care’ approach for the de-
livery of time-limited, focused psychological treatment (high or
low intensity intervention). Regular outcome and session-by-
session monitoring data are collected via validated question-
naires of social functioning and symptoms, allowing progress to
be routinely tracked.
IAPT services are commissioned with the remit of improving the
health and well-being of their clients. One of the Key Performance
Indicators that IAPT services are evaluated on is the rate of people
‘moving towards recovery’. This has been operationally deﬁned as
an individual moving from a ‘case’ at pre-treatment to ‘non-case’ at
post treatment based on scores on speciﬁc symptom measures for
depression and anxiety. Recent national reports indicate that
approximately 45% of those entering IAPT services achieve recovery
status at the end of treatment and one report found that only 3nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Mental Health team Health and Social Care Information Centre,
2014, 2015; Gyani et al., 2011). Little is known about what charac-
teristics predict an individual's response to treatment in IAPT ser-
vices and the identiﬁcation of predictors of treatment outcome
could enable services to tailor their interventions more effectively
and improve outcomes.
Although CBT is generally associated with medium-to-large ef-
fect sizes for depression and anxiety disorders (Butler, Chapman,
Forman, & Beck, 2006; Cuijpers et al., 2013, 2014; Hoffman &
Smits, 2008; Olatunji et al., 2014; Twomey, O'Reilly, & Byrne,
2014), there is heterogeneity in outcome, with initial symptom
severity being an established risk factor for poorer treatment
outcome (Haby, Donnelly, Corry, & Vos, 2006). Other predictors of
poor response to CBT, and more speciﬁcally IAPT treatment, are
more elusive, although a potentially important prognostic factor is
the presence of co-morbid personality difﬁculties. The presence of a
comorbid personality disorder has been shown to adversely affect
treatment outcome for depression (e.g. Gorwood et al., 2010;
Newton-Howes, Tyrer, & Johnson, 2006) and speciﬁc personality
disorder diagnoses also appear to be associated with a poorer
prognosis for certain anxiety disorders (Black, Wesner, Gabel,
Bowers, & Monahan, 1994; Hansen, Vogel, Stiles, & G€otestam,
2007; Steketee, Chambless, & Tran, 2001; Telch, Kamphuis, &
Schmidt, 2011). However, the ﬁndings are mixed since other
studies report null effects (e.g. Joyce et al., 2007; Kampman,
Keijsers, Hoogduin, & Hendriks, 2008). Therefore personality dis-
order may be a highly relevant prognostic factor for IAPT treatment.
Individuals with a personality disorder suffer from high rates
of comorbid depression and anxiety (Fribourg, Martinussen,
Kaiser, Øvergard, & Rosenveinge, 2013; Zanarini et al., 1998).
Moreover, compared to individuals without a co-morbid person-
ality disorder, those with a co-morbid personality disorder may
experience more episodes of depression and anxiety in the past,
and tend to experience a more chronic course of illness
(Gunderson et al., 2008). There are, however, no data available on
the prevalence or impact of personality disorder in individuals
accessing IAPT services. The prevalence of personality disorder
among those attending primary care services (a setting from
which substantial numbers of IAPT referrals derive) is known to be
high (Moran, Jenkins, Tylee, Blizard, & Mann, 2000). Potentially,
IAPT services may therefore be seeing large numbers of people
with hitherto unrecognised personality difﬁculties or frank per-
sonality disorder. It is unclear whether the occurrence of these
difﬁculties has an adverse impact on the effectiveness of psy-
chological treatment offered by IAPT services.
Using a prospective cohort study design, we set out to examine
whether the likely presence of personality disorder independently
predicted treatment outcomes in a large established IAPT service in
London. Based on the existing literature, we hypothesised that
increased risk of a personality disorder would independently pre-
dict higher levels of symptomatology, greater functional impair-
ment, and persistent caseness and reduced change at end of
treatment. Secondary hypotheses were that, compared to in-
dividuals at lower risk of personality disorder, individuals at high
risk of personality disorder would be more likely to drop out of
treatment.
2. Method
2.1. Setting
Southwark Psychological Therapies Service (SPTS) is one of
the 35 UK sites that initially implemented the IAPT programme.
The majority of referrals are from the GP or self-referrals.Individual referrals are reviewed and clients are asked to com-
plete an assessment battery, which includes a variety of de-
mographic and clinical questionnaires (see Measures below), by
post. Individuals are then offered an initial assessment appoint-
ment with a clinician, either on the telephone or face to face. The
treatment options are discussed with the individual and a
treatment plan is collaboratively agreed based on a number of
factors, such as symptom severity, patient choice, and logistics.
CBT is the predominant approach adopted by the service in both
low and high intensity interventions.
2.2. Population, sample and data extraction
IAPTus is an online, secure electronic database where clinicians
input data routinely collected on clients. For the purposes of this
study, data were extracted from the IAPTus electronic patient
database for all individuals who had attended an initial assessment
session (phone or face to face) between January 1st 2012 and
December 31st 2012 inclusive and who had a rating of personality
disorder (n ¼ 1249). All individuals were adults aged 18 or above.
Some individuals were referred more than once during the speci-
ﬁed time period and to ensure independence of data, only one
treatment episode per person was included in the analysis. Of the
1249 individuals, 1005 individuals (81%) had end of treatment
ratings of symptoms and these individuals formed the analytic
sample.
2.3. Measures
The assessment battery includes validated self-report ques-
tionnaires for symptoms and functioning. Those listed below
were used in analyses for the present study. Demographic data
were collected via the initial assessment form. Clinical details
(number of sessions, treatment allocation, and reason for end of
treatment) were recorded by the treating therapist.
2.3.1. Patient health questionnaire (PHQ-9; Kroenke, Spitzer, &
Williams, 2001)
This is a validated 9-item measure of depression completed at
initial assessment and every clinical contact. A score of 10 is
considered to be of clinical signiﬁcance and is used as a cut-off to
identify caseness. The PHQ-9 has good internal consistency when
applied in primary care populations (a ¼ .89; Kroenke et al.,
2001).
2.3.2. Generalised anxiety disorder assessment (GAD-7; Spitzer,
Kroenke, Williams, & Lowe, 2006)
This is a validated 7 item measure of anxiety completed at
initial assessment and every clinical contact. A score of 8 is
considered to be of clinical signiﬁcance and is used as a cut off to
identify caseness. Although developed to measure generalised
anxiety disorder, the measure has satisfactory psychometric
properties for detecting a range of anxiety disorders (Kroenke,
Spitzer, Williams, Monahan, & Lowe, 2007) and has good inter-
nal consistency when applied in primary care (a ¼ .92; Spitzer
et al., 2006).
2.3.3. Work and social adjustment scale (W&SAS; Mundt, Isaac,
Shear, & Greist, 2002)
This is a validated 5-item measure of impaired functioning
completed at the initial assessment and every clinical contact.
The W&SAS assesses the impact of an individual's mental
health difﬁculties on their work, home management, social lei-
sure activities, private leisure activities and relationships. The
W&SAS has good internal consistency when applied in
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et al., 2002).2.3.4. Standardised assessment of personality e abbreviated scale
(SAPAS; Moran et al., 2003)
This is an 8-item scale that is completed at the initial
assessment only. The self-report version of the SAPAS is an
adequate alternative to the mini interview from which it was
derived, with no loss of speciﬁcity and sensitivity (Germans, van
Heck, Moran, & Hodiamont, 2008). Recipients are asked to
indicate whether they endorse a particular personality trait in
general using a dichotomous yes/no response format. The sum-
med score (0e8) represents the likelihood of a person having a
personality disorder (i.e. a higher score indicates higher risk) and
does not aim to screen for speciﬁc personality disorder cate-
gories. The original validation study found that using a cut off
score of 3 or 4 on the SAPAS correctly identiﬁed 80% of patients
as having a personality disorder in a psychiatric population
(Moran et al., 2003). The measure has been further validated in
samples of patients with substance dependency (Hesse & Moran,
2010) and in large outpatient populations of patients with
depression (Bukh, Bock, Vinberg, Gether, & Kessing, 2010;
Gorwood et al., 2010). The internal consistency in the present
sample was a ¼ .6.2.4. Ethics
The study was part of a wider service evaluation, for which all
individuals accessing SPTS had consented to their anonymised
information being stored on an electronic database and used for
evaluation purposes. This project was approved by the South
London and Maudsley NHS Trust Mood, Anxiety and Personality
Clinical Academic Group audit committee.Table 1
Demographic data for individuals who attended an initial assessment in 2012 and
had a completed SAPAS available.
M (SD)
Age 36.2 (12.1)
N %
Sex
Male 357 35.6
Female 645 64.4
Ethnicity
Any White 686 73.7
Caribbean or mixed Caribbean 68 7.2
African or mixed African 48 5.1
Any other Black 29 3.1
Asian or mixed Asian 38 4.0
Any other mixed 17 1.8
Any other ethnic group 29 3.1
Not stated 6 .6
Employment
Employed 521 53.9
Unemployed and seeking work 119 12.3
Student (FT or PT) not seeking work 88 9.1
Long term sick or disabled 141 14.6
Homemaker not seeking paid work 40 4.1
Not receiving beneﬁts, not working or seeking work 29 3.0
Retired 20 2.1
Sick pay
No 874 90.4
Yes 51 5.3
Unknown/not stated 42 4.3
KEY: M ¼ Mean; SD¼ Standard deviation; N¼Number of people; FT¼ Full time;
PT¼ Part time; SAPAS: Standardised Assessment of Personalitye Abbreviated Scale.2.5. Data analysis
Normally distributed demographic and clinical data were
described using means and standard deviations. Frequency data
were presented where appropriate. Between-group comparisons
were made using t-tests or Chi square tests. Multiple linear and
logistic regression analyses were used to examine the predictive
value of clinical information obtained at initial assessment on
outcome at end of treatment. Dependent variables were contin-
uous scores on PHQ-9, GAD-7 and W&SAS at last clinical contact
and dummy coded binary variables to indicate casesness on PHQ-
9 (10) and GAD-7 (8). Change scores were derived as depen-
dent variables, by subtracting the ﬁnal score from the initial score
on the same measure. Therefore, a large absolute value indicates
more change than a smaller value, and negative values indicate a
deterioration in clinical presentation. In addition, reason for end
of treatment was dummy coded to represent whether an indi-
vidual had completed treatment (scheduled vs unscheduled
discontinuation of therapy) and was used as a dependent variable
in logistic regression analyses for those who had attended 2 or
more sessions. Independent variables that were entered into
regression models were: age, gender, SAPAS score, initial assess-
ment scores for PHQ-9, GAD-7 and W&SAS (in order to adjust for
baseline symptom severity) and the number of sessions attended.
ICD-10 diagnostic codes are not reported in this report as a recent
report found that they were not reliably entered (Nasrin, unpub-
lished data) and do not affect predictive models of outcome (Gyani
et al., 2011). Statistical signiﬁcance was set at p ¼ .05 but raw p
values are shown.3. Results
3.1. Sample description
Demographic data for the sample are presented in Table 1. The
majority of the sample were female and of White ethnic origin.
Fifty-four percent were employed at time of initial assessment.
Forty-seven percent of the present sample completed the treat-
ment, 35% prematurely discontinued treatment, 17% were referred
on to another service, and 2% were coded as not suitable for the
service. Forty-seven percent of the sample was initially allocated to
low intensity treatment and 54% was initially allocated to high
intensity treatment. Individuals with higher SAPAS scores were
more likely to be allocated to high intensity interventions (B ¼ .15,
SE ¼ .04, Wald ¼ 11.3, p ¼ .001, odds ratio ¼ 1.2, 95% CI ¼ 1.1e1.3).
Individuals who received at least two sessions (i.e. it was assumed
they received some form of treatment) received an average of 9.1
sessions in total (SD ¼ 6.6).3.2. Missing data
Thirty-four percent of the sample did not have paired outcome
data available (i.e. last session scores for PHQ-9, GAD-7 or W&SAS).
Those who had paired outcomes were signiﬁcantly older (M ¼ 37.1,
SD¼ 12.1) than those who did not have paired outcomes (M¼ 34.6,
SD ¼ 12.1) (t(987) ¼ 2.97, p ¼ .003) and had signiﬁcantly higher
ﬁrst session PHQ-9 (M ¼ 15.6, SD ¼ 7.2 versus M ¼ 13.4, SD ¼ 6.5;
t(560.4) ¼ 4.6, p < .001; equal variances not assumed), GAD-7
(M ¼ 13.0, SD ¼ 5.9 versus M ¼ 11.8, SD ¼ 5.4; t(979) ¼ 3.0,
p ¼ .003) and SAPAS (M ¼ 4.3, SD ¼ 2.0 versus M ¼ 3.8, SD ¼ 1.9;
t(627.2) ¼ 3.5, p ¼ .001; equal variances not assumed) scores
compared to those who did not have last session outcome data
available. There were no differences between groups on the
W&SAS. Individuals who did not have paired outcome measures
attended an average of 1.8 sessions (SD ¼ 1.2). Individuals who had
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those who did not (p ¼ .09).3.3. Does baseline SAPAS score independently predict clinical
outcomes at the end of treatment?
SAPAS scores were positively and signiﬁcantly associated with
initial session PHQ-9 (r ¼ .40, p < .001), GAD-7 (r ¼ .41,
SD ¼ p < .001) and W&SAS (r ¼ .29, p < .001) scores. SAPAS scores
were also positively and signiﬁcantly correlated with ﬁnal PHQ-9
(r ¼ .27, p < .001), GAD-7 (r ¼ .30, p < .001), and W&SAS (r ¼ .26,
p < .001) scores.
SAPAS total score was entered as a predictor in three multiple
regression models with last session scores of PHQ-9, GAD-7 and
W&SAS as the dependent variable (Table 2). The models were all
highly signiﬁcant and accounted for approximately one third of the
variance in outcome. Higher SAPAS scores independently predicted
a greater number of depression and anxiety symptoms, and greater
functional impairment at last session. The addition of SAPAS to each
model resulted in small, statistically signiﬁcant changes in R2 for all
dependent variables (R-squared change estimate (D R2) with the
addition of SAPAS to PHQ-9 model ¼ .005, p ¼ .02; D R2 with the
addition of SAPAS to GAD-7 model ¼ .009, p ¼ .003; D R2 with the
addition of SAPAS to W&SAS model ¼ .004, p ¼ .03).
We used binary logistic regression to examine the effect of
SAPAS total score on “moving towards recovery status”. Analyses
included only individuals who met caseness criteria for PHQ-9
(10) or GAD-7 (8) at initial assessment respectively. Higher
initial PHQ-9 (B ¼ .17, SE ¼ .03, Wald ¼ 33.5, p < .001, odds
ratio ¼ 1.19, 95% CI ¼ 1.1e1.3), lower number of sessions (B ¼ .16,
SE ¼ .02, Wald ¼ 107.1, p < .001, odds ratio ¼ .8, 95% CI ¼ .8e.9) andTable 2
Regression models examining predictors of PHQ-9, GAD-7 andW&SAS scores at end
of treatment.
B (SE) Beta t p 95% CI
Dependent variable: last session PHQ-9
F(7, 648) ¼ 51.72, p < .001; Adj. R2 ¼ .35
Gender .18 (.47) .01 .38 .706 1.1e.75
Age .04 (.02) .07 2.20 .028 .00e.08
Number of sessions .23 (.03) .22 6.77 .000 .30 to .17
PHQ-9 First .53 (.05) .49 10.12 .000 .43e.63
GAD-7 First .00 (.06) .00 .07 .946 .11e.12
W&SAS First .06 (.03) .07 1.92 .055 .00e.11
SAPAS .29 (.13) .08 2.28 .023 .04e.56
Dependent variable: last session GAD-7
F(7, 648) ¼ 42.66, p < .001; Adj. R2 ¼ .32
Gender .05 (.41) .00 .12 .908 .85e.75
Age .03 (.02) .06 1.80 .072 .00e.06
Number of sessions .20 (.03) .22 6.82 .000 .26 to .15
PHQ-9 First .23 (.05) .25 5.07 .000 .14e.32
GAD-7 First .29 (.05) .26 5.70 .000 .19e.39
W&SAS First .03 (.03) .05 1.24 .216 .02e.08
SAPAS .34 (.11) .11 3.03 .003 .12e.57
Dependent variable: last session W&SAS
F(7, 648) ¼ 51.18, p < .001; Adj. R2 ¼ .35
Gender .12 (.64) .01 .19 .848 1.1e1.4
Age .02 (.03) .03 .91 .363 .03e.07
Number of sessions .21 (.05) .14 4.39 .000 .30 to .11
PHQ-9 First .44 (.07) .30 6.31 .000 .31e.59
GAD-7 First .13 (.08) .07 1.64 .102 .29e.03
W&SAS First .40 (.04) .39 10.20 .000 .33e.48
SAPAS .38 (.18) .07 2.13 .034 .03e.73
KEY: PHQ-9: Patient Health Questionnaire; GAD-7: Generalised Anxiety Disorder
assessment; W&SAS: Work and Social Adjustment Scale; SAPAS: Standardised
Assessment of Personality e Abbreviated Scale.
R-squared change estimate (DR2) with the addition of SAPAS to PHQ-9model¼ .005,
p ¼ .02; DR2 with the addition of SAPAS to GAD-7 model ¼ .009, p ¼ .003; D R2 with
the addition of SAPAS to W&SAS model ¼ .004, p ¼ .03.
p values <.05 are highlighted in bold.higher SAPAS scores (B ¼ .12, SE ¼ .06, Wald ¼ 3.9, p ¼ .047, odds
ratio ¼ 1.1, 95% CI ¼ 1.0e1.3) independently predicted an increased
likelihood of persistent caseness for PHQ-9 after controlling for
demographic (age, gender) and initial symptom and functioning
scores (overall model effect: c2 ¼ 4.0, p ¼ .046). Similarly, higher
PHQ-9 (B ¼ .08, SE ¼ .02, Wald ¼ 12.9, p < .001, odds ratio ¼ 1.08,
95% CI ¼ 1.0e1.1), lower number of sessions (B ¼ .18, SE ¼ .02,
Wald ¼ 122.8, p < .001, odds ratio ¼ .8, 95% CI ¼ .8e.9) and higher
SAPAS scores (B ¼ .12, SE ¼ .06, Wald ¼ 5.1, p ¼ .024, odds
ratio ¼ 1.13, 95% CI ¼ 1.0e1.3) independently predicted an
increased likelihood of persistent caseness for GAD-7 after con-
trolling for demographic (age, gender) and initial symptom and
functioning scores (overall model effect: c2 ¼ 5.1, p ¼ .24). Of note,
neither age nor gender, nor initial GAD-7 nor W&SAS signiﬁcantly
predicted persistent caseness at end of treatment.
3.4. Is SAPAS score associated with amount of change on PHQ-9,
GAD-7 and W&SAS?
Table 3 displays the results obtained from linear regression
analyses examining predictors of change scores. After controlling
for the effects of age, sex, initial symptom scores and the number of
clinical sessions, higher SAPAS scores independently predicted less
change on clinical (PHQ-9 and GAD-7) and functional (W&SAS)
outcomes. The addition of SAPAS to themodels was associated with
small, signiﬁcant improvements in R2. Models accounted for
20e30% of the variance (Table 3).
3.5. Does SAPAS score predict differences in treatment engagement?
Individuals who had an unscheduled discontinuation (i.e.
dropped out of treatment or failed to engage; excluding those whoTable 3
Regression models examining predictors of amount of change over treatment.
B (SE) Beta t P 95% CI
Dependent variable: Change in PHQ-9
F(7, 648) ¼ 27.90, p < .001; Adj. R2 ¼ .22
Gender .18 (.47) .01 .38 .706 .75e1.1
Age .04 (.02) .08 2.20 .028 .08 to .00
PHQ-9 First .47 (.05) .48 9.05 .000 .37e.57
GAD-7 First .00 (.06) .00 .07 .946 .12e.11
W&SAS First .06 (.03) .08 1.92 .055 .11e.00
SAPAS .30 (.13) .09 2.28 .023 .56 to .04
Number of sessions .23 (.03) .24 6.77 .000 .17e.30
Dependent variable: Change in GAD-7
F(7, 648) ¼ 40.65, p < .001; Adj. R2 ¼ .30
Gender .05 (.41) .00 .12 .908 .75e.85
Age .03 (.02) .06 1.80 .072 .06e.00
PHQ-9 First .23 (.05) .25 5.07 .000 .32 to .14
GAD-7 First .71 (.05) .65 13.89 .000 .61e.81
W&SAS First .03 (.03) .05 1.24 .216 .08e.02
SAPAS .34 (.11) .11 3.03 .003 .57 to .12
Number of sessions .20 (.03) .23 6.82 .000 .15e.26
Dependent variable: Change in W&SAS
F(7, 648) ¼ 39.79, p < .001; Adj. R2 ¼ .29
Gender .12 (.64) .01 .19 .848 1.4e1.1
Age .02 (.03) .03 .91 .363 .07e.03
PHQ-9 First .45 (.07) .32 6.31 .000 .59 to .31
GAD-7 First .13 (.08) .08 1.64 .102 .03e.29
W&SAS First .60 (.04) .60 15.09 .000 .52e.67
SAPAS .38 (.18) .08 2.13 .034 .73 to .03
Number sessions .21 (.05) .15 4.39 .000 .11e.30
PHQ-9: Patient Health Questionnaire; GAD-7: Generalised Anxiety Disorder
assessment; W&SAS: Work and Social Adjustment Scale; SAPAS: Standardised
Assessment of Personality e Abbreviated Scale.
R-squared change estimate (DR2) with the addition of SAPAS to PHQ-9model¼ .006,
p ¼ .02; D R2 with the addition of SAPAS to GAD-7 model ¼ .010, p ¼ .003; DR2 with
the addition of SAPAS to W&SAS model ¼ .005, p ¼ .03.
p values <.05 are highlighted in bold.
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had signiﬁcantly higher SAPAS scores (M ¼ 4.09, SD ¼ 1.86,
N ¼ 349) than those who completed treatment (M ¼ 3.70,
SD ¼ 1.92, N ¼ 467) (t(814) ¼ 2.86, p ¼ .004). We therefore
examined whether there was an independent association between
SAPAS score and discontinuation from treatment. After adjusting
for the effects of potential confounders in a binary logistic regres-
sion model (i.e. age, gender, initial PHQ-9, GAD-7, and W&SAS
scores), SAPAS score did not independently predict treatment
completion status (p ¼ .39). This was however predicted by lower
baseline depression score (B¼.07, SE ¼ .02, Wald statistic¼ 17.77
p < .001, odds ratio ¼ .93, 95% CI ¼ .90 - .96), higher baseline
functional impairment score (B ¼ .02, SE ¼ .01, Wald
statistic ¼ 5.43, p ¼ .020, odds ratio ¼ 1.0, 95% CI ¼ 1.0e1.0) and
older age (B ¼ .02, SE ¼ .01, Wald statistic ¼ 11.92, p ¼ .001, odds
ratio ¼ 1.0, 95% CI ¼ 1.0e1.0).
4. Discussion
In this large sample of IAPT attenders with anxiety and
depression, the likely presence of co-morbid personality disorder,
as indexed by the SAPAS, was independently associatedwith poorer
outcomes at end of treatment. Higher SAPAS scores predicted
higher symptom scores on both the PHQ-9 and GAD-7 and greater
functional impairment measured by the W&SAS at last clinical
contact and this associationwas independent of the effects of initial
symptom score and demographic background. Higher SAPAS scores
also predicted persistent caseness at end of treatment for both
PHQ-9 and GAD-7. We therefore veriﬁed our primary hypothesis. In
addition, after controlling for demographic and clinical variables
and the number of sessions, higher SAPAS scores predicted reduced
raw change on all outcomes. The absolute increase in predictive
power of the models with the addition of SAPAS data was signiﬁ-
cant but modest. Nevertheless, our models conﬁrmed that per-
sonality difﬁculties are independently associated with poorer
treatment outcomes in IAPT. Finally, it was hypothesised that
higher SAPAS scores would be associated with higher rates of un-
scheduled discontinuation of treatment. This hypothesis was not
supported; instead the data suggested that treatment completion
was associated with lower baseline depression score, higher func-
tional impairment and older age.
4.1. Comparison to previous studies
To our knowledge, the only available analysis of predictors of
recovery within IAPT services was a report conducted by Gyani and
colleagues based on data from 32 of the ﬁrst wave of IAPT sites
(Gyani et al., 2011). This report found that 42.4% of people achieved
the ‘moving towards recovery’ status and approximately 64% of
people made reliable improvement. Severe symptomatology was
associated with reduced recovery rates but greater absolute change
and this was replicated in the current study. In addition, the report
found that a greater number of sessions was associated with more
improvement, and that those with more severe symptomatology
were more likely to receive a greater number of sessions (Gyani
et al., 2011). To date, there have been no other published studies
reporting clear predictors of treatment outcome in IAPT services,
although the protocol for a study that is at an early stage has been
published (Grant et al., 2014). The current ﬁndings are consistent
with others studies reporting that the presence of personality
disorder adversely affects treatment outcome for depression. In
contrast, Joyce et al. (2007) found that personality disorder was
associated with poorer outcomes in Interpersonal psychotherapy
but not CBT for depression. Differences in methodology (e.g. clinical
interview vs short screening measure) or sample size may explainthese differences in results. Also, the participants in Joyce et al.
(2007) study received 16 sessions of weekly therapy whereas the
mean number of sessions in the present study was 9. It is possible
that there is an effect of time and that with more sessions the effect
of a personality disorder on treatment response attenuates. Indeed,
Steketee et al. (2001) suggest that individuals with personality
difﬁculties are more cautious to engage in treatment and progress
may be slower than for individuals without personality difﬁculties.
Our results are also consistent with literature on the impact of
personality disorder on treatment for anxiety disorders (e.g. Black
et al., 1994; Hansen et al., 2007; Latas & Milovanovic, 2014;
Steketee et al., 2001; Telch et al., 2011). In contrast, Dreessen,
Arntz, Luttels, and Sallaerts (1994) argue that individuals with
personality disorders show a similar amount of change after
treatment for anxiety disorders, although their higher initial
symptom severity is associated with higher symptom scores at end
of treatment. Importantly, our study showed an effect of high risk of
personality disorder on both end of treatment scores and raw
change over the course of treatment even after controlling for the
confounding effects of initial symptom scores. In addition, the ef-
fect was not explained by the potential confounding effects of age,
gender, or the number of treatment sessions received.
The presence of a personality disorder may affect treatment
outcomes through a number of mechanisms, including increased
rates of treatment drop out (Jinks, McMurran, & Huband, 2012;
McMurran, Huband, & Overton, 2010; O'Brien, Fahmy, & Singh,
2009; Percudani, Belloni, Contini, & Barbui, 2002; Tyrer et al.,
2010), service related factors (Crawford et al., 2009), the occur-
rence of a more fragile therapeutic alliance (Bienfeld, 2007;
Martino, Menchetti, Pozzi, & Beradi, 2012), or through reduced
patient or clinician expectations (Martino et al., 2012; Ramon,
Castillo, & Morant, 2001). Personality disorder might be assumed
to have an adverse impact on attendance for treatment. However,
we found that although individuals with high SAPAS scores were
less likely to continue treatment compared to thosewith low SAPAS
scores, this association was confounded by higher symptom
severity on the PHQ-9. Therapist factors (particularly, experience,
and levels of supervision and training) are likely to also be very
important in determining the efﬁcacy of treatment but we were
unable to explore this issue in this study.
4.2. Implications
There is a growing need and expectation of mental health ser-
vices in the UK to make psychological therapies available to in-
dividuals with severe mental illness, including personality disorder
(Department of Health, 2011). The data presented in this paper
indicate that IAPT services are certainly being accessed by groups of
individuals at high risk of a personality disorder and that these
individuals do respond to treatment for their anxiety and depres-
sion, albeit with smaller effects. Our study has shown that the in-
clusion of a short personality screening assessment in the initial
assessment battery provides potentially useful prognostic infor-
mation and this information could be used to enhance the provi-
sion of IAPT services for these individuals. For example, clinicians
and service users could use a brief personality assessment to
explore how co-occurring personality difﬁculties may relate to
their presenting difﬁculties with depression and anxiety. This in-
formationmay also guide clinicians in the delivery of treatment, for
example, by highlighting a need to focus more on core beliefs
compared to automatic thoughts (Bienfeld, 2007), to include spe-
ciﬁc skills training or structured clinical management as part of
treatment (Bateman & Fonagy, 2005), and to give greater consid-
eration to the impact of the ending of therapy on individuals with
co-morbid personality difﬁculties.
E. Goddard et al. / Behaviour Research and Therapy 73 (2015) 1e76As the IAPT programme expands its remit, it is essential that
IAPT staff receive adequate training and supervision on the
assessment and treatment of individuals with signiﬁcant person-
ality difﬁculties, as well as the impact these difﬁculties have on the
presenting depression and anxiety. Such training may lead to
improved treatment outcomes, as well as improved awareness of
the impact of personality disorders on the team, the therapeutic
relationship and on individual clinicians. The consideration of how
personality difﬁculties inﬂuence an individual's clinical presenta-
tion will help inform the response of IAPT services to these in-
dividuals. The provision of a reﬂective space for clinicians may
support them in maintaining a therapeutic stance and prevent a
sense of hopelessness that may ensue as a result of signiﬁcant
numbers of individuals not attaining the desired “moving towards
recovery” status.
5. Methodological considerations
Key strengths of this study include its prospective and prag-
matic design, large sample size, and the fact that we controlled for
initial symptom severity in outcome analyses and examined both
end of treatment scores as well as change scores (Dreessen et al.,
1994). However, there are also limitations to this study that need
to be considered. Self-report measures of personality disorder may
over-estimate personality pathology compared to clinical in-
terviews (e.g. Chambless, Renneberg, Goldstein, & Gracely, 1992).
Diagnostic data on personality disorder is not routinely collected by
IAPT services and so we are unable to comment on the likely extent
of over-diagnosis in this sample. However, the SAPAS has good
diagnostic speciﬁcity when compared against a standardised
interview (.85 at cut-point of 3 in the original validation study;
Moran et al., 2003) and is a pragmatic alternative to lengthy in-
terviews that could not possibly be conducted in the busy setting of
an IAPT service. The internal consistency of the SAPAS in the pre-
sent study is comparable to that obtained in other samples
(Germans et al., 2008). Alpha values are dependent on the number
of scale items and the dimensionality of the underlying construct
being measured. The SAPAS is screening for a heterogeneous and
multidimensional construct (the broad category of personality
disorder) and we would therefore not anticipate a high level of
internal consistency. Individuals who did not have paired outcome
data available, and were therefore not included in the present
analysis, had more severe initial symptom and SAPAS scores than
those for whom the complete data were available. This introduces
the possibility of selection bias and it is uncertain whether the
relationships presented in this paper can be generalised to a group
with more severe symptoms.
The present study could not differentiate between different
types of personality disorder or treatment types and it is possible
that different personality subtypes have differential effects on
outcome. Also, it was not possible to analyse the data according to
treatment type, although the vast majority of people are offered
CBT and stratifying the data by treatment type would have yiel-
ded under-powered analyses. Future research should examine
these issues further. The present study did not analyse data ac-
cording to diagnostic category of outcomes (e.g. depression,
speciﬁc anxiety disorder diagnoses) and it is possible that the
disorder speciﬁc treatments for Axis 1 disorders are differentially
affected by personality disorder. Personality disorder is associ-
ated with recurrent depression, but we were unable to adjust for
the potential confounding effects of the number of previous ep-
isodes, nor duration of illness. Nonetheless, Gorwood et al. (2010)
found that personality disorder was a stronger predictor of
treatment outcome than the number of previous episodes of
depression. Other potential confounding factors which we wereunable to examine include therapist factors (e.g. age, experience,
supervision and training) and the socio-economic status of the
patient.
6. Summary
In summary, the current study found that individuals at risk of a
personality disorder are less likely to have a favourable response to
psychological treatment as delivered by an IAPT service. The use of
a brief screening tool for personality disorder can provide valuable
prognostic information and this may inform the delivery of more
effective treatment. Patients presenting with co-morbid personal-
ity difﬁculties to IAPT services may potentially require an adapted
form of psychological treatment if they are to beneﬁt from treat-
ment to the same extent as patients presenting with depression
and anxiety without co-morbid personality difﬁculties. In addition,
IAPT services may need to consider providing additional training
and supervision on the management of personality disorder, in
order to ensure that therapists are able to provide effective in-
terventions to individuals presenting with more complex psycho-
logical difﬁculties.
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